Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 1.9M | $7.4M | 4% | Mar 2024 |
|
| Vanguard Group | 1.6M | $6.3M | 5% | Mar 2024 |
|
| Geode Capital Management | 654k | $2.6M | 9% | Mar 2024 |
|
| Susquehanna International | 361k | $1.4M | -27% | Mar 2024 |
|
| Integrys Wealth Advisors | 355k | $1.4M | 5% | Mar 2024 |
|
| Northern Trust | 241k | $955k | -2% | Mar 2024 |
|
| Wolverine Trading | 235k | $929k | 100% | Mar 2024 |
|
| Sofinnova Ventures | 143k | $565k | 0% | Mar 2024 |
|
| Citadel Advisors | 132k | $523k | -67% | Mar 2024 |
|
| LPL Financial | 129k | $509k | -45% | Mar 2024 |
|
| Nuveen Asset Management | 110k | $437k | 5% | Mar 2024 |
|
| Bank of New York Mellon | 99k | $391k | -8% | Mar 2024 |
|
| Goldman Sachs Group | 91k | $358k | 625% | Mar 2024 |
|
| Bank of America Corporation | 82k | $326k | -3% | Mar 2024 |
|
| Commonwealth Equity Services | 80k | $316k | 4% | Mar 2024 |
|
| Charles Schwab Investment Management | 77k | $306k | 0% | Mar 2024 |
|
| Jane Street | 75k | $298k | 270% | Mar 2024 |
|
| Amussen Hunsaker & Associates | 75k | $295k | 0% | Mar 2024 |
|
| Morgan Stanley | 73k | $288k | 6% | Mar 2024 |
|
| XTX Topco | 60k | $239k | 100% | Mar 2024 |
|
| UBS Group | 43k | $170k | 171% | Mar 2024 |
|
| Marshall Wace | 41k | $163k | 100% | Mar 2024 |
|
| William Blair $ Company | 40k | $158k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 40k | $157k | -6% | Mar 2024 |
|
| Alliancebernstein | 38k | $188k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 35k | $139k | 4% | Mar 2024 |
|
| Vontobel Holding | 32k | $127k | -22% | Mar 2024 |
|
| Group One Trading | 31k | $121k | -26% | Mar 2024 |
|
| Simplex Trading | 22k | $85k | -14% | Mar 2024 |
|
| AQR Capital Management | 21k | $83k | -29% | Mar 2024 |
|
| Barclays | 20k | $78k | -49% | Mar 2024 |
|
| T. Rowe Price Associates | 18k | $70k | 11% | Mar 2024 |
|
| Rathbones Brothers | 16k | $63k | 5% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 15k | $61k | -28% | Mar 2024 |
|
| Wealth Group | 15k | $61k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 15k | $74k | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 14k | $56k | 4% | Mar 2024 |
|
| American International | 14k | $69k | 0% | Dec 2023 |
|
| Raymond James & Associates | 14k | $55k | -43% | Mar 2024 |
|
| Mercer Global Advisors | 13k | $50k | 0% | Mar 2024 |
|
| Lazari Capital Management | 12k | $60k | 9% | Dec 2023 |
|
| Jpmorgan Chase & Co | 12k | $47k | -41% | Mar 2024 |
|
| Wells Fargo & Company | 11k | $42k | 44% | Mar 2024 |
|
| GSA Capital Partners | 10k | $41k | 100% | Mar 2024 |
|
| EP Wealth Advisors | 10k | $51k | 0% | Dec 2023 |
|
| Federation des caisses Desjardins du Quebec | 9.0k | $36k | 100% | Mar 2024 |
|
| Kathleen S. Wright Associates | 7.0k | $28k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 5.3k | $21k | 2000% | Mar 2024 |
|
| Citigroup | 4.8k | $19k | 19% | Mar 2024 |
|
| Tower Research Capital | 4.2k | $16k | 190% | Mar 2024 |
|
| Legal & General Group | 3.0k | $12k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 3.0k | $11k | -73% | Mar 2024 |
|
| California State Teachers Retirement System | 2.8k | $11k | -54% | Mar 2024 |
|
| Summit Investment Advisors | 2.3k | $9.1k | 0% | Mar 2024 |
|
| New York State Common Retirement Fund | 2.2k | $9.0k | 135% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.5k | $7.7k | 0% | Dec 2023 |
|
| FMR | 1.4k | $5.4k | -10% | Mar 2024 |
|
| ICA Group Wealth Management | 1.0k | $4.1k | 732% | Mar 2024 |
|
| Amalgamated Bank | 943.00 | $4.0k | -76% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 400.00 | $1.0k | 0% | Mar 2024 |
|
| JJJ Advisors | 287.00 | $1.1k | 0% | Mar 2024 |
|
| CWM | 61.00 | $0 | 0% | Mar 2024 |
|
| NISA Investment Advisors | 59.00 | $233.999900 | 100% | Mar 2024 |
|
| Pnc Financial Services | 8.00 | $32.000000 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $19.000000 | 100% | Mar 2024 |
|
Who sold out of Pds Biotechnology Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Dec 2023 | 400k | $2.0M |
| Leucadia National Corporation | Dec 2023 | 400k | $2.0M |
| Two Sigma Advisers | Dec 2023 | 109k | $542k |
| Caption Management | Dec 2023 | 58k | $289k |
| Mirae Asset Global Investments | Dec 2023 | 52k | $256k |
| D. E. Shaw & Co | Dec 2023 | 50k | $247k |
| Two Sigma Investments | Dec 2023 | 41k | $202k |
| Trexquant Investment | Sep 2023 | 26k | $131k |
| Verition Fund Management | Sep 2023 | 26k | $130k |
| Nebula Research & Development | Sep 2023 | 26k | $130k |
| Virtu Financial | Dec 2023 | 25k | $124k |
| ALPS Advisors | Sep 2023 | 23k | $115k |
| Jump Financial | Sep 2023 | 17k | $86k |
| Corton Capital | Dec 2023 | 15k | $75k |
| Squarepoint Ops | Dec 2023 | 13k | $65k |
| Millennium Management | Dec 2023 | 13k | $63k |
| Ing Investment Management | Sep 2023 | 11k | $57k |
| SG Americas Securities | Dec 2023 | 11k | $52k |
| Lindbrook Capital | Dec 2023 | 500.00 | $2.5k |
| IFP Advisors | Sep 2023 | 11.00 | $55.999900 |